Drug
Heplisav And OR Placebo
Heplisav And OR Placebo: highest development phase Phase 3, developed by Dynavax Technologies. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Dynavax Technologies
Trials
| Drug | Phase | Indication |
|---|---|---|
| HEPLISAV and/or Placebo NCT00435812 | Phase 3 | Hepatitis B |
| HEPLISAV and/or Placebo NCT01005407 | Phase 3 | Healthy |
Latest
No recent events.
Follow Heplisav And OR Placebo on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.